Ryan Fischesser, VP of Finance and Controller at Caribou Biosciences, Inc. (CRBU), bought 1,136 shares at $2.69 ($3K) on 2021-12-20, disclosed to the SEC on 2021-12-21.
Open-market purchase of $3k CRBU by VP of Finance and Controller. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CRBU | BUY | 2021-10-12 | $5K | — | Filing → |